Chemkart India: No Deviation in IPO Fund Use for H1 FY27

Chemkart India Ltd has submitted its Regulation 32 Statement for the Half Year ended September 30, 2026, confirming no deviation or variation in the utilization of IPO proceeds. The statement, reviewed by the Audit Committee and approved by the Board of Directors on October 30, 2026, indicates that out of ₹64.47 Crore raised, ₹39.48 Crore was utilized as of September 30, 2026, leaving ₹24.99 Crore unutilized. Key utilization areas included financing capital expenditure for a manufacturing facility through its wholly-owned subsidiary, Easy Raw Materials Private Limited (₹34.68 Crore allocated, ₹9.69 Crore utilized), and repayment of borrowings (₹20.00 Crore allocated, ₹20.00 Crore utilized). General corporate purposes and IPO expenses accounted for ₹9.79 Crore utilized out of ₹9.79 Crore allocated.